145 related articles for article (PubMed ID: 15577583)
1. Thyroid blocking policy--revisited.
Solanki KK; Bomanji JB; Waddington WA; Ell PJ;
Nucl Med Commun; 2004 Nov; 25(11):1071-6. PubMed ID: 15577583
[No Abstract] [Full Text] [Related]
2. Whole-body scanning with radionuclides of iodine, and the controversy of "thyroid stunning".
Kalinyak JE; McDougall IR
Nucl Med Commun; 2004 Sep; 25(9):883-9. PubMed ID: 15319592
[No Abstract] [Full Text] [Related]
3. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131.
Sfakianakis G; Sfakianaki E
Hell J Nucl Med; 2007; 10(1):2-5. PubMed ID: 17450241
[TBL] [Abstract][Full Text] [Related]
4. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
Lassmann M; Luster M; Hänscheid H; Reiners C
J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
[No Abstract] [Full Text] [Related]
5. The British Thyroid Association guidelines for the management of thyroid cancer in adults.
Watkinson JC;
Nucl Med Commun; 2004 Sep; 25(9):897-900. PubMed ID: 15319594
[No Abstract] [Full Text] [Related]
6. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
7. Thyroid stunning revisited.
Woolfenden JM
J Nucl Med; 2006 Sep; 47(9):1403-5. PubMed ID: 16954545
[No Abstract] [Full Text] [Related]
8. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer.
Son H; Lee SM; Yoon RG; Lee H; Lee I; Kim S; Chung WY; Lee JW
Hell J Nucl Med; 2017; 20(1):62-70. PubMed ID: 28315910
[TBL] [Abstract][Full Text] [Related]
9. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
Sacks W; Wong RM; Bresee C; Braunstein GD
Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
[TBL] [Abstract][Full Text] [Related]
10. Thyroid stunning in vivo and in vitro.
Medvedec M
Nucl Med Commun; 2005 Aug; 26(8):731-5. PubMed ID: 16000993
[TBL] [Abstract][Full Text] [Related]
11. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
[TBL] [Abstract][Full Text] [Related]
12. [Iodide load: the antidote for the risk of thyroid irradiation in case of nuclear accident].
Orgiazzi J
Rev Prat; 2015 Jan; 65(1):95-6. PubMed ID: 25842446
[No Abstract] [Full Text] [Related]
13. Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse.
Goffredo P; Thomas SM; Dinan MA; Perkins JM; Roman SA; Sosa JA
JAMA Intern Med; 2015 Apr; 175(4):638-40. PubMed ID: 25686394
[No Abstract] [Full Text] [Related]
14. The 2009 American Thyroid Association guidelines modestly reduced radioactive iodine use for thyroid cancers less than 1 cm.
Roman BR; Feingold JH; Patel SG; Shaha AR; Shah JP; Tuttle RM; Epstein AJ
Thyroid; 2014 Oct; 24(10):1549-50. PubMed ID: 25065817
[No Abstract] [Full Text] [Related]
15. Re: the so-called stunning of thyroid tissue.
Hilditch TE; Bolster AA; Dempsey MF; Reed NS
J Nucl Med; 2007 Apr; 48(4):675-6; author reply 676. PubMed ID: 17401107
[No Abstract] [Full Text] [Related]
16. Thyroid remnant ablation following administration of a diagnostic dose of iodine-131 under thyrogen stimulation.
Wu D; Fink-Bennett D; Campbell J
Thyroid; 2014 May; 24(5):924-5. PubMed ID: 24483713
[No Abstract] [Full Text] [Related]
17. Thyroid cancer: an overview.
Haq M; Harmer C
Nucl Med Commun; 2004 Sep; 25(9):861-7. PubMed ID: 15319589
[No Abstract] [Full Text] [Related]
18. Current issues in the management of differentiated thyroid cancer.
Mallick UK; Charalambous H
Nucl Med Commun; 2004 Sep; 25(9):873-81. PubMed ID: 15319591
[No Abstract] [Full Text] [Related]
19. [The preparation and study of potassium-iodide preparations for the protection of the thyroid gland after contamination with radioactive iodine (131I)].
Nidzović Z; Popović R; Bodiroga M; Odavić M
Vojnosanit Pregl; 1989; 46(5):330-3. PubMed ID: 2609505
[TBL] [Abstract][Full Text] [Related]
20. Re: does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Lam MG; van Isselt JW
J Nucl Med; 2005 Dec; 46(12):2118; author reply 2118-9. PubMed ID: 16330579
[No Abstract] [Full Text] [Related]
[Next] [New Search]
